Taloxa, Suspension zum Einnehmen
7680526790284
CH-52679
suspension
Associated product:
TALOXA susp 600mg/5ml 230 ml
1 / 3
google
Article details
- Package size
- 230
- Selling units
- 230
- Measure
- ml
- Galenic form
- suspension
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
600.0 MG | Substance | Wirkstoff (Principe actif) |
|
cellulosum microcristallinum et carmellosum natricum
|
- | Substance | HNIDK |
|
sorbitolum liquidum cristallisabile
|
1.5 G | Substance | HBESI |
|
glycerolum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
simeticoni emulsio
|
- | Substance | HNIDK |
|
ethanolum
|
1.08 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | AIMDK |
|
aqua purificata
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | AIMDK |
|
natrium
|
2.804 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
Reimbursement information
Public price
CHF 118.95
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1998
Authorization holder
Organon GmbH
6006 Luzern
Authorization information
- Swissmedic authorization number
- 52679
- Drug name
- Taloxa, Suspension zum Einnehmen
- Galenic form
- SUOR
- ATC Code
- N03AX10
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 25/02/1997
- Authorization expiration date
- 31/12/9999
- IT Number
- 01.07.1.
- Domain
- Human medicine
Package details
- Description (FR)
- TALOXA susp 600mg/5ml 230 ml
- Description (DE)
- TALOXA Susp 600mg/5ml 230 ml
- Market launch
- 25/02/1997
- Narcotic (BTM)
- No